Sintx Technologies (SINT) Divestments (2018)

Sintx Technologies' (SINT) quarterly Divestments came in at -$76000.0 in Q2 2018, down 145.16% quarter-over-quarter from -$31000.0 in Q1 2018.

Sintx Technologies (SINT) Divestments (2018) Analysis & Trends

Sintx Technologies' Divestments history runs 1 years deep, the most recent figure standing at -$76000.0 for Q2 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 9.37 Mn
10 Sintx Technologies 6.02 Mn 4.13 Mn 144,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2018 -76,000.00
Mar 31, 2018 -31,000.00